This week in gene and cell therapy - 5 January 2018

Gene and cell therapy headlines 1 - 5 January

UK healthcare agency NICE approves Strimvelis for ADA-SCID

Price for Luxturna set at $425.000 per eye 

Gene therapy restores normal blood glucose levels in mice with type 1 diabetes

CAR T cells may be able to help fight HIV